Painchek Ltd
Research Painchek Ltd (PCK) on Bullrun: market cap AUD 20.48M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerPCK
- ExchangeAU
- CountryAustralia
- SectorHealthcare
- IndustryHealth Information Services
- CurrencyAUD
- Market capAUD 20.48M
- Financial periodFY2025
Valuation Snapshot
latest market cap is AUD 20.48M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | n/a | n/a | n/a | n/a | -0.04 | n/a | n/a | n/a |
| FY2024 | AUD 2.67M | -AUD 8.31M | -AUD 7.16M | 27.0% | -0.06 | AUD 3.56M | n/a | AUD 1.29M |
| FY2023 | AUD 1.95M | -AUD 7.57M | -AUD 6.34M | 36.5% | -0.06 | AUD 2.51M | n/a | AUD 668.13K |
| FY2022 | AUD 978.57K | -AUD 5.72M | -AUD 7.02M | -26.4% | -0.05 | AUD 6.14M | n/a | AUD 4.82M |
| FY2021 | AUD 214.80K | -AUD 6.06M | -AUD 4.18M | -197.5% | n/a | AUD 11.42M | n/a | AUD 8.24M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-23 | AUD 20.48M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 AUD.
About Painchek Ltd
PainChek Limited develops and commercialized mobile medical device applications that provides pain assessment for individuals in Australia, the United Kingdom, and internationally. The company offers PainChek, a clinically validated and regulatory cleared pain assessment technology that uses cameras in smartphones for a facial scan that is analyzed using facial recognition software to indicate the presence of pain. It serves patients suffering with dementia and pre-verbal infants;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Painchek Ltd's market cap?
Painchek Ltd's market capitalization is AUD 20.48M.
What does Painchek Ltd do?
PainChek Limited develops and commercialized mobile medical device applications that provides pain assessment for individuals in Australia, the United Kingdom, and internationally. The company offers PainChek, a clinically validated and regulatory cleared pain assessment technology that uses cameras in smartphones for a facial scan that is analyzed using facial recognition software to indicate the presence of pain. It serves patients suffering with dementia and pre-verbal infants; and the aged care, disability, home care, hospital, and infant sectors.